Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Mind the gap! Lay and medical perceptions of risks associated with the use of alternative treatment and conventional medicine.
Generation and preclinical characterization of an antibody specific for SEMA4D.
Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury.
Neuromyelitis optica spectrum disorder and multiple sclerosis: Differentiation by a multimodal approach.
Endothelin-B Receptor Activation in Astrocytes Regulates the Rate of Oligodendrocyte Regeneration during Remyelination.
Should MRI be the primary endpoint of phase 3 trials in multiple sclerosis?
Axonal expression of sodium channels and neuropathology of the plaques in multiple sclerosis.
Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.
Multiple sclerosis: Defect in peripheral B-cell tolerance identified in MS.
MRI lesions: a surrogate for relapses in multiple sclerosis?
Recent evidence for an expanded role of the kynurenine pathway of tryptophan metabolism in neurological diseases.
Deficiency of CD8+ effector memory T cells is an early and persistent feature of multiple sclerosis.
Serum 25(OH) Vitamin D levels is not associated with disability in multiple sclerosis patients: A case-control study.
Functional connectivity underlying postural motor adaptation in people with multiple sclerosis.
Differential effects of genetic susceptibility factors in males and females with multiple sclerosis.
Neurology in the developing world.
Noise robust spatially regularized myelin water fraction mapping with the intrinsic B1 -error correction based on the linearized version of the extended phase graph model.
Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice.
Meningeal inflammation in multiple sclerosis: The key to the origin of cortical lesions?
Performance of Apparent Diffusion Coefficient Values and Conventional MRI Features in Differentiating Tumefactive Demyelinating Lesions From Primary Brain Neoplasms.
Atypical presentation of multiple sclerosis.
Correction: MRI Correlates of Disability in African-Americans with Multiple Sclerosis.
The role of dopamine in modulation of Th-17 immune response in multiple sclerosis.
Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.
Anthocyanin effects on microglia M1/M2 phenotype: Consequence on neuronal fractalkine expression.
Pages
« first
‹ previous
…
596
597
598
599
600
601
602
603
604
…
next ›
last »